Form 4 for SLSN SOLESENCE, INC.
Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-26 · accession 0001209191-21-067223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-30 | 2021-11-26+ | SLSN | Cureton Kevin | COO | M - OptEx | $0.481 | +61.6K | 49.6K | New | +$29.6K |
| DM | 2021-11-30 | 2021-11-26+ | SLSN | Cureton Kevin | COO | S - Sale+OE | $3.69 | -36.4K | 50.8K | -42% | -$134.4K |
| DM | 2021-11-30 | 2021-11-26+ | SLSN | Cureton Kevin | COO | M - OptEx | $0.481 | -61.6K | 25.0K | -71% | -$29.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-26 | M | A | 12,607 | $0.52 | 38,257 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-26 | S | D | 12,607 | $3.50 | 25,650 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-30 | S | D | 23,829 | $3.79 | 50,821 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-30 | M | A | 25,000 | $0.52 | 74,650 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-30 | M | A | 24,000 | $0.42 | 49,650 | D | — | — | |
| 6 | Derivative | Common Stock | 2021-11-26 | M | D | 12,607 | $0.52 | 0 | D | $0.52 · 2014-02-14 to 2023-02-14 | 12,607 Common Stock | (F3) Following the recently reported exercise of 12,393 shares (11/24/21), this line item represents the 2nd exercise, of 12,607 shares of a total initial grant of 75,000 shares, leaving a balance of 50,000 shares remaining relating to this grant, prior to the 11/30/21 exercise reported below. (F2) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 7 | Derivative | Common Stock (right to purchase) | 2021-11-30 | M | D | 24,000 | $0.42 | 0 | D | $0.42 · 2014-02-14 to 2023-02-14 | 24,000 Common Stock | (F1) Following recently reported exercises of 11,668 (11/22/21) and 12,332 (11/24/21) shares, this line item represents the 3rd exercise, of 24,000 shares of the total initial grant of 48,000 shares, leaving a balance of 0 shares remaining relating to this grant. (F2) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 8 | Derivative | Common Stock (right to purchase) | 2021-11-30 | M | D | 25,000 | $0.52 | 25,000 | D | $0.52 · 2015-02-13 to 2024-02-13 | 50,000 Common Stock | (F4) Following the recently reported exercise of 12,393 shares (11/24/21), and the 2nd exercise of 12,607 shares (11/26/21, reported above) this line item represents the 3rd exercise, of 25,000 shares of the total initial grant of 75,000 shares, leaving a balance of 25,000 shares remaining relating to this grant. (F2) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |